|
Can CRISPR-Based Covid-19 Testing Using Smartphones Slow The Pandemic?
|
|
0
|
432
|
December 13, 2020
|
|
Diagnosis and clinical outcomes of extrapulmonary tuberculosis in antiretroviral therapy programmes in low‐ and middle‐income countries: a multicohort study
|
|
0
|
432
|
September 13, 2019
|
|
Assessment and initial management of acute undifferentiated fevers in tropical and subtropical regions
|
|
0
|
432
|
December 3, 2018
|
|
Determine TB-LAM point-of-care tuberculosis assay in South Africa
|
|
0
|
431
|
August 11, 2020
|
|
Let’s Worry About Diagnostic Capacity, Not Just During Outbreaks
|
|
0
|
431
|
February 19, 2020
|
|
Webinar: How to engage private laboratories in TB diagnostics
|
|
0
|
430
|
February 22, 2021
|
|
CHAI releases first-ever Hepatitis C Market Report
|
|
0
|
430
|
May 29, 2020
|
|
FIND Update on COVID-19 Diagnostics
|
|
0
|
430
|
March 4, 2020
|
|
Monitoring quality indicators for the Xpert MTB/RIF molecular assay in Ethiopia
|
|
0
|
430
|
November 21, 2019
|
|
Upcoming conference: Accelerating Innovation and Access in Global Health Technologies
|
|
0
|
430
|
February 5, 2019
|
|
Trial network to support diagnostics developers
|
|
0
|
429
|
December 1, 2020
|
|
COVID-19: Behind SA’s shortages of test materials
|
|
0
|
429
|
May 5, 2020
|
|
Neglected Tropical Diseases: A Lesson in Elimination?
|
|
0
|
429
|
February 10, 2020
|
|
Deep Learning Algorithms Are Expected To Boost Liquid Biopsy Techniques
|
|
0
|
429
|
May 28, 2019
|
|
Molecular methods for antimicrobial resistance (AMR) diagnostics to enhance the Global Antimicrobial Resistance Surveillance System
|
|
0
|
429
|
March 1, 2019
|
|
The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal Swabs
|
|
0
|
428
|
January 12, 2021
|
|
Tuberculosis diagnosis and treatment under uncertainty
|
|
0
|
428
|
November 28, 2019
|
|
Artificial Intelligence to help detect blindness related to diabetes
|
|
0
|
428
|
April 30, 2019
|
|
COVID 19 response: Protecting gains made against tuberculosis
|
|
0
|
427
|
July 23, 2020
|
|
Coalition of public and private sector partners launches SDG500, a US$ 500 million investment platform to accelerate progress towards the SDGs
|
|
0
|
427
|
January 24, 2020
|
|
Open Letter to Cepheid: Time to lower the price of Xpert cartridges to US$5
|
|
0
|
427
|
January 9, 2020
|
|
Artificial Intelligence, Radiology, and Tuberculosis: A Review
|
|
0
|
427
|
November 23, 2019
|
|
Resistance to diagnostics
|
|
0
|
426
|
December 22, 2019
|
|
Evaluating diagnostic tests during outbreaks: challenges and lessons learnt from COVID-19
|
|
0
|
425
|
July 24, 2023
|
|
Impact of a personalised, digital, HIV self-testing app-based program
|
|
0
|
425
|
September 2, 2021
|
|
Tuberculosis And Covid-19: Fighting A Deadly Syndemic
|
|
0
|
425
|
September 26, 2020
|
|
Detection and quantification of TB using ddPCR
|
|
0
|
425
|
May 11, 2020
|
|
Call for proposals for evaluation of new TB diagnostics and testing strategies
|
|
0
|
424
|
November 18, 2020
|
|
What will it take to eliminate drug-resistant tuberculosis?
|
|
0
|
424
|
May 22, 2019
|
|
Keeping the Promise: PDP’s Role in the New Age of Health Research and Product Development
|
|
0
|
423
|
January 22, 2021
|
|
Comparing accuracy of lipoarabinomannan urine tests for diagnosis of pulmonary tuberculosis in children
|
|
0
|
423
|
December 14, 2020
|
|
Scaling up HIV Viral Load testing_challenges and opportunities
|
|
0
|
423
|
January 8, 2020
|
|
Innovative WHO HIV testing recommendations aim to expand treatment coverage
|
|
0
|
423
|
November 29, 2019
|
|
Blood Culture Results Before and After Antimicrobial Administration in Patients With Severe Manifestations of Sepsis: A Diagnostic Study
|
|
0
|
423
|
September 17, 2019
|
|
Deciphering drug resistance in Mycobacterium tuberculosis using whole-genome sequencing: progress, promise, and challenges
|
|
0
|
423
|
July 30, 2019
|
|
Health Technology Assessment in India: A Manual
|
|
0
|
422
|
August 29, 2019
|
|
Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection
|
|
0
|
421
|
August 26, 2020
|
|
Variable and shifting (user-) settings in developing point-of-care diagnostics for tuberculosis and HIV
|
|
0
|
421
|
January 19, 2020
|
|
Comparative performance of four rapid Ebola antigen-detection lateral flow immunoassays
|
|
0
|
421
|
April 15, 2019
|
|
Nigeria publishes new guidelines on Lassa fever management
|
|
0
|
421
|
February 20, 2019
|
|
Global Fund, Stop TB Partnership and USAID Announce New Collaboration with Danaher to Reduce Price and Increase Access to Cepheid’s TB Test
|
|
0
|
420
|
September 20, 2023
|
|
The evolution of imaging and portable imaging tools to aid tuberculosis diagnosis
|
|
0
|
420
|
September 5, 2023
|
|
Asia emerges as a hotbed of diagnostic innovations for tuberculosis
|
|
0
|
420
|
August 28, 2021
|
|
FIND’s Actionable Diagnostic Data for Improved TB Care (ADDforTB) Initiative
|
|
0
|
420
|
December 10, 2019
|
|
Teleradiology and Artificial Intelligence – Birds of the Same Feather
|
|
0
|
420
|
December 10, 2019
|
|
Spit in a Tube and Mail It In: A New Frontier in Coronavirus Testing
|
|
0
|
419
|
December 3, 2020
|
|
What the WHO's List of Essential Diagnostics means for clinical microbiology laboratories and antimicrobial stewardship practice worldwide
|
|
0
|
419
|
June 3, 2019
|
|
ACT-A Dx Knowledge Hub
|
|
0
|
418
|
March 2, 2023
|
|
Senior Epidemiologist and Tech Scouting Position for TB Diagnostics open in Heidelberg, Germany
|
|
0
|
418
|
October 30, 2020
|
|
Syphilis diagnosis and treatment during antenatal care: the potential catalytic impact of the dual HIV and syphilis rapid diagnostic test
|
|
0
|
418
|
July 22, 2019
|